The Federal Trade Commission has sued drug middlemen that health insurance plans use to control drug spending, accusing the companies of inflating insulin prices.
The Federal Trade Commission has sued drug middlemen that health insurance plans use to control drug spending, accusing the companies of inflating insulin prices.
